Amy Burroughs, Terns Pharma CEO, joins ‘Closing Bell Overtime’ to talk progress in its GLP-1 drug development.
Source link
Trending
- American Airlines lifts ground stop after flights were halted for a technical issue
- ‘I don’t digest food properly now’: The all-consuming pressure of managing a football club
- These stocks will be biggest Nasdaq losers of 2025, according to analysts
- A guide to Christmas-themed trading cards: From Santa Claus to Clark Griswold
- Here are Wall Street’s favorite Nasdaq stocks for 2025
- Tech billionaire shares his 5-word piece of advice for a successful future
- Airlines brace for record travel
- Digital health stocks pummeled by Wall Street in 2024, but Hims surges
Terns CEO Amy Burroughs on oral GLP-1 offering
